Last synced on 2 May 2025 at 11:05 pm

Sirolimus Test System

Page Type
Product Code
Definition
Sirolimus test systems are intended for the quantitative measurement of sirolimus in whole blood as an aid in management of transplant patients taking this sirolimus.
Regulation Medical Specialty
Toxicology
Review Panel
Toxicology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
862.3840
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Third Party Eligible

CFR § 862.3840 Sirolimus test system

§ 862.3840 Sirolimus test system.

(a) Identification. A sirolimus test system is a device intended to quantitatively determine sirolimus concentrations in whole blood. Measurements are used as an aid in management of transplant patients receiving therapy with sirolimus.

(b) Classification. Class II (special controls). The special control is FDA's guidance document entitled “Class II Special Controls Guidance Document: Sirolimus Test Systems.” See § 862.1(d) for the availability of this guidance document.

[69 FR 58259, Sept. 30, 2004]

Sirolimus Test System

Page Type
Product Code
Definition
Sirolimus test systems are intended for the quantitative measurement of sirolimus in whole blood as an aid in management of transplant patients taking this sirolimus.
Regulation Medical Specialty
Toxicology
Review Panel
Toxicology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
862.3840
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Third Party Eligible

CFR § 862.3840 Sirolimus test system

§ 862.3840 Sirolimus test system.

(a) Identification. A sirolimus test system is a device intended to quantitatively determine sirolimus concentrations in whole blood. Measurements are used as an aid in management of transplant patients receiving therapy with sirolimus.

(b) Classification. Class II (special controls). The special control is FDA's guidance document entitled “Class II Special Controls Guidance Document: Sirolimus Test Systems.” See § 862.1(d) for the availability of this guidance document.

[69 FR 58259, Sept. 30, 2004]